| 000 | 01189 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250515001709.0 | ||
| 264 | 0 | _c20051114 | |
| 008 | 200511s 0 0 eng d | ||
| 022 | _a0007-1161 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNguyen, Q D | |
| 245 | 0 | 0 |
_aBevacizumab suppresses choroidal neovascularisation caused by pathological myopia. _h[electronic resource] |
| 260 |
_bThe British journal of ophthalmology _cOct 2005 |
||
| 300 |
_a1368-70 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 | _aBevacizumab |
| 650 | 0 | 4 |
_aChoroidal Neovascularization _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyopia, Degenerative _xcomplications |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xantagonists & inhibitors |
| 700 | 1 | _aShah, S | |
| 700 | 1 | _aTatlipinar, S | |
| 700 | 1 | _aDo, D V | |
| 700 | 1 | _aAnden, E V | |
| 700 | 1 | _aCampochiaro, P A | |
| 773 | 0 |
_tThe British journal of ophthalmology _gvol. 89 _gno. 10 _gp. 1368-70 |
|
| 999 |
_c15802461 _d15802461 |
||